GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 105 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $17,525,000 | +93.4% | 733,300 | +18.1% | 0.91% | +67.5% |
| Q4 2020 | $9,063,000 | +225.4% | 620,800 | +216.6% | 0.54% | +131.6% |
| Q3 2020 | $2,785,000 | -2.2% | 196,100 | +1.2% | 0.23% | -10.3% |
| Q2 2020 | $2,849,000 | +482.6% | 193,700 | +63.2% | 0.26% | +342.4% |
| Q1 2020 | $489,000 | +1.7% | 118,700 | +18.6% | 0.06% | +59.5% |
| Q4 2019 | $481,000 | +77.5% | 100,100 | +123.9% | 0.04% | +54.2% |
| Q3 2019 | $271,000 | +113.4% | 44,700 | +126.9% | 0.02% | +100.0% |
| Q2 2019 | $127,000 | -9.3% | 19,700 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $140,000 | +45.8% | 19,700 | 0.0% | 0.01% | +33.3% |
| Q4 2018 | $96,000 | -33.3% | 19,700 | 0.0% | 0.01% | -18.2% |
| Q3 2018 | $144,000 | +51.6% | 19,700 | +32.2% | 0.01% | +37.5% |
| Q2 2018 | $95,000 | – | 14,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,365,000 | $16,186,000 | 1.49% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,517,767 | $26,540,000 | 1.17% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 1,590,000 | $7,646,000 | 1.04% |
| Parkman Healthcare Partners LLC | 420,000 | $2,020,000 | 0.58% |
| Penn Capital Management Company, LLC | 977,526 | $4,702,000 | 0.49% |
| Bullseye Asset Management LLC | 79,272 | $381,000 | 0.37% |
| Bellevue Group AG | 2,441,241 | $11,742,000 | 0.19% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,783 | $1,447,000 | 0.18% |
| Granite Investment Partners, LLC | 589,313 | $2,835,000 | 0.13% |
| WRAPMANAGER INC | 68,163 | $328,000 | 0.10% |